What You'll Learn:
Dr. David Acheson, President and CEO of the Acheson Group, joined us for an update on current FSMA activities and to answer submitted questions. This session included discussion about the Intentional Adulteration Rule, current FDA focus and inspection activities, regulatory activities, whole genome sequencing, and environmental monitoring.